AbbVie Inc. stock outperforms competitors despite losses on the day
AbbVie Inc. closed 15.68% short of its 52-week high of $207.32, which the company achieved on October 31st.
Is AbbVie Inc. (ABBV) the Best Stock to Buy in 2025 for Beginners?
We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...
A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $212.73, a high ...
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...
Piramal Pharma Ltd: Piramal Pharma Limited Announces Results for Q3 and 9M FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today ...
Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue ...
MarketWatch19h
Prologis Inc.
Link Parks Inc. Dep. Pfd. (Rep. 1/1000th 5.25% Cum. Redeem. Pfd. Series X) 0.00% Link Parks Inc. Dep. Pfd. (Rep. 1/1000th Share 4.875% Pfd. Series Z) 0.00% Link Parks ...